Chalcone organohalogen: thiết kế, tổng hợp, dự đoán ADMET, nghiên cứu động lực học phân tử và hiệu ứng ức chế trên acetylcholinesterase và carbonic anhydrase

Mahmudov I, Demir Y, Sert Y, Abdullayev Y, Sujayev A, Alwasel SH, Gulcin I (2022) Synthesis and inhibition profiles of N-benzyl-and N-allyl aniline derivatives against carbonic anhydrase and acetylcholinesterase–a molecular docking study. Arab J Chem 15(3):103645. https://doi.org/10.1016/j.arabjc.2021.103645 Hoff E, Zou D, Schiza S, Demir Y, Grote L, Bouloukaki I, Hedner J (2020) Carbonic anhydrase, obstructive sleep apnea and hypertension: effects of intervention. J Sleep Res 29(2):e12956. https://doi.org/10.1111/jsr.12956 Sever B, Türkeş C, Altıntop MD, Demir Y, Akalın Çiftçi G, Beydemir Ş (2021) Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Arch Pharm 354(12):2100294. https://doi.org/10.1002/ardp.202100294 Yaşar Ü, Gönül İ, Türkeş C, Demir Y, Beydemir Ş (2021) Transition-metal complexes of bidentate Schiff-Base ligands: in vitro and in silico evaluation as non-classical carbonic anhydrase and potential acetylcholinesterase inhibitors. ChemistrySelect 6(29):7278–7284. https://doi.org/10.1002/slct.202102082 Aydin BO, Anil D, Demir Y (2021) Synthesis of N-alkylated pyrazolo [3, 4-d] pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties. Arch Pharm 354(5):2000330. https://doi.org/10.1002/ardp.202000330 Boron WF (2010) Evaluating the role of carbonic anhydrases in the transport of HCO3−-related species. Biochim Biophys Acta 1804(2):410–421 Kaya Y, Erçağ A, Zorlu Y, Demir Y, Gülçin İ (2022) New Pd (II) complexes of the bisthiocarbohydrazones derived from isatin and disubstituted salicylaldehydes: synthesis, characterization, crystal structures and inhibitory properties against some metabolic enzymes. J Biol Inorg Chem 27(2):271–281. https://doi.org/10.1007/s00775-022-01932-9 Hamide M, Gök Y, Demir Y, Yakalı G, Tok TT, Aktaş A, Gülçin İ (2022) Pentafluorobenzyl-substituted benzimidazolium salts: synthesis, characterization, crystal structures, computational studies and inhibitory properties of some metabolic enzymes. J Mol Struct. https://doi.org/10.1016/j.molstruc.2022.133266 Aggarwal M, Boone CD, Kondeti B, McKenna R (2013) Structural annotation of human carbonic anhydrases. J Enzyme Inhib Med Chem 28(2):267–277. https://doi.org/10.3109/14756366.2012.737323 Kakakhan C, Türkeş C, Güleç Ö, Demir Y, Arslan M, Özkemahlı G, Beydemir Ş (2023) Exploration of 1, 2, 3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase. Bioorg Med Chem 77:117111. https://doi.org/10.1016/j.bmc.2022.117111 Supuran CT (2008) Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 14(7):641–648. https://doi.org/10.2174/138161208783877947 Maren TH (1987) Carbonic anhydrase: general perspective and advances in glaucoma research. Drug Dev Res 10(4):255–276. https://doi.org/10.1002/ddr.430100407 Rao PP, Sulekha S, Maithili DVN, Nallari P (2006) Carbonic anhydrase-II phenotypes in peptic Ulcer and Ulcerated cancers. Int J Hum Genet 6(2):153–158. https://doi.org/10.1080/09723757.2006.11885956 De Simone G, Supuran CT (2007) Antiobesity carbonic anhydrase inhibitors. Curr Top Med Chem 7(9):879–884. https://doi.org/10.2174/156802607780636762 Supuran CT (2008) Carbonic anhydrase inhibitors: possible anticancer drugs with a novel mechanism of action. Drug Dev Res 69(6):297–303 Demir Y, Türkeş C, Çavuş MS, Erdoğan M, Muğlu H, Yakan H, Beydemir Ş (2022) Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3, 5-dimethoxy benzaldehyde motif. Arch Pharm. https://doi.org/10.1002/ardp.202200554 Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules 25(24):5789. https://doi.org/10.3390/molecules25245789 Ozaslan M, Saglamtas R, Demir Y, Genc Y, Saraçoğlu İ, Gülçin İ (2022) Isolation of some phenolic compounds from Plantago subulata L. and determination of their antidiabetic, anticholinesterase, antiepileptic and antioxidant activity. Chem Biodivers. https://doi.org/10.1002/cbdv.202200280 World Health Organization (2017) Global action plan on the public health response to dementia. 2017–2025. Osmaniye D, Türkeş C, Demir Y, Özkay Y, Beydemir Ş, Kaplancıklı ZA (2022) Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors. Arch Pharm 355(8):2200132. https://doi.org/10.1002/ardp.202200132 Güleç Ö, Türkeş C, Arslan M, Demir Y, Yeni Y, Hacımüftüoğlu A, Beydemir Ş (2022) Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1, 3, 4-oxadiazol structural motif. Mol Divers 26(5):2825–2845. https://doi.org/10.1007/s11030-022-10422-8 Bilginer S, Gul HI, Anil B, Demir Y, Gulcin I (2021) Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors. Arch Pharm 354(1):2000243. https://doi.org/10.1002/ardp.202000243 Tugrak M, Gul HI, Demir Y, Levent S, Gulcin I (2021) Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides. Arch Pharm 354(4):2000375. https://doi.org/10.1002/ardp.202000375 Türkan F, Huyut Z, Demir Y, Ertaş F, Beydemir Ş (2019) The effects of some cephalosporins on acetylcholinesterase and glutathione S-transferase: an in vivo and in vitro study. Arch Physiol Biochem 125(3):235–243. https://doi.org/10.1080/13813455.2018.1452037 Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, Height JJ (2012) Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55(22):10282–10286. https://doi.org/10.1021/jm300871x Talesa VN (2001) Acetylcholinesterase in Alzheimer’s disease. Mech Ageing Dev 22(16):1961–1969. https://doi.org/10.1016/S0047-6374(01)00309-8 Pereira GRC, Gonçalves LM, Abrahim-Vieira BDA, De Mesquita JF (2022) In silico analyses of a promising drug candidate for the treatment of amyotrophic lateral sclerosis targeting superoxide dismutase I protein. J Cell Biochem 123(7):1259–1277. https://doi.org/10.3390/pharmaceutics15041095 García-Ayllón MS, Small DH, Avila J, Sáez-Valero JN (2011) Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid. Front Mol Neurosci 4:22. https://doi.org/10.3389/fnmol.2011.00022 Marucci G, Buccioni M, Dal Ben D, Lambertucci C, Volpini R, Amenta F (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology 190:108352. https://doi.org/10.1016/j.neuropharm.2020.108352 Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D (2013) Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur J Med Chem 70:165–188. https://doi.org/10.1016/j.ejmech.2013.09.050 Anil DA, Aydin BO, Demir Y, Turkmenoglu B (2022) Design, synthesis, biological evaluation and molecular docking studies of novel 1H–1, 2, 3-Triazole derivatives as potent inhibitors of carbonic anhydrase, acetylcholinesterase and aldose reductase. J Mol Struct 1257:132613. https://doi.org/10.1016/j.molstruc.2022.132613 Kalaycı M, Türkeş C, Arslan M, Demir Y, Beydemir Ş (2021) Novel benzoic acid derivatives: synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors. Arch Pharm 354(3):2000282. https://doi.org/10.1002/ardp.202000282 Burmaoglu S, Algul O, Anıl DA, Gobek A, Duran GG, Ersan RH, Duran N (2016) Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Bioorg Med Chem Lett 26(13):3172–3176. https://doi.org/10.1016/j.bmcl.2016.04.096 Burmaoglu S, Aktas Anil D, Gobek A, Kilic D, Yetkin D, Duran N, Algul O (2022) Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives. J Biomol Struct Dyn 40(8):3525–3550. https://doi.org/10.1080/07391102.2020.1848627 Ouyang Y, Li J, Chen X, Fu X, Sun S, Wu Q (2021) Chalcone derivatives: role in anticancer therapy. Biomolecules 11(6):894. https://doi.org/10.3390/biom11060894 Jesus A, Durães F, Szemerédi N, Freitas-Silva J, da Costa PM, Pinto E, Cidade H (2022) BDDE-inspired chalcone derivatives to fight bacterial and fungal infections. Mar Drugs 20(5):315. https://doi.org/10.3390/md20050315 Burmaoglu S, Algul O, Gobek A, Aktas Anil D, Ulger M, Erturk BG, Aslan G (2017) Design of potent fluoro-substituted chalcones as antimicrobial agents. J Enzyme İnhib Med Chem 32(1):490–495. https://doi.org/10.1080/14756366.2016.1265517 Duran N, Polat MF, Aktas DA, Alagoz MA, Ay E, Cimen F, Algul O (2021) New chalcone derivatives as effective against SARS-CoV-2 agent. Int J Clin Pract 75(12):e14846. https://doi.org/10.1111/ijcp.14846 Elkhalifa D, Al-Hashimi I, Al Moustafa AE, Khalil A (2021) A comprehensive review on the antiviral activities of chalcones. J Drug Target 29(4):403–419. https://doi.org/10.1080/1061186X.2020.1853759 Thapa P, Upadhyay SP, Suo WZ, Singh V, Gurung P, Lee ES, Sharma M (2021) Chalcone and its analogs: therapeutic and diagnostic applications in Alzheimer’s disease. Bioorg Chem 108:104681. https://doi.org/10.1016/j.bioorg.2021.104681 Wilcken R, Zimmermann MO, Lange A, Joerger AC, Boeckler FM (2013) Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J Med Chem 56(4):1363–1388. https://doi.org/10.1021/jm3012068 Anil DA, Polat MF, Saglamtas R, Tarikogullari AH, Alagoz MA, Gulcin I, Burmaoglu S (2022) Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: synthesis, characterization and molecular modeling studies. Comput Biol Chem 100:107748. https://doi.org/10.1016/j.compbiolchem.2022.107748 Burmaoglu S, Kazancioglu EA, Kaya R, Kazancioglu M, Karaman M, Algul O, Gulcin I (2020) Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects. J Mol Struct 1208:127868. https://doi.org/10.1016/j.molstruc.2020.127868 Mughal EU, Sadiq A, Naeem AN, Javid A, Sumrra SH, Zafar MN, Khan BA, Malik FP, Ahmed I (2020) Exploring 3-benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure–activity relationship and molecular modelling simulations. J Mol Struct Dyn 39(16):6154–6167. https://doi.org/10.1080/07391102.2020.1803136 Greenblatt HM, Dvir H, Silman I, Sussman JL (2003) Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease. J Mol Neurosci 20:369–383. https://doi.org/10.1385/JMN:20:3:369 George RF, Said MF, Bua S, Supuran CT (2020) Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII. Bioorg Chem 95:103514. https://doi.org/10.1016/j.bioorg.2019.103514 Cabaleiro-Lago C, Lundqvist M (2020) The effect of nanoparticles on the structure and enzymatic activity of human carbonic anhydrase I and II. Molecules 25:4405. https://doi.org/10.3390/molecules25194405 Bora RF, Genc Bilgicli H, Üç EM, Alagöz MA, Zengin M, Gulcin İ (2022) Synthesis, characterization, evaluation of metabolic enzyme inhibitors and in silico studies of thymol based 2-amino thiol and sulfonic acid compounds. Chem Biol Interact 366:110134. https://doi.org/10.1016/j.cbi.2022.110134 Hou Z, Cai Q, Cheng M (2021) Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: synthesis, biological and molecular docking analysis. Bioorg Med Chem Lett 51:128291. https://doi.org/10.1016/j.bmcl.2021.128291 Winum JY, Scozzafava A, Montero JL, Supuran CT (2006) New zinc binding motifs in the design of selective carbonic anhydrase inhibitors. Mini-Rev Med Chem 6:921–936. https://doi.org/10.2174/138955706777934946 Xu Y, Cheng S, Sussman JL, Silman I, Jiang H (2017) Computational studies on acetylcholinesterases. Molecules 22:1324. https://doi.org/10.3390/molecules22081324 Ali M, Bozdag M, Farooq U, Angeli A, Carta F, Berto P, Supuran CT (2020) Benzylaminoethyureido-tailed benzenesulfonamides: design, synthesis, kinetic and X-ray investigations on human carbonic anhydrases. Int J Mol Sci 21(7):2560 Ersan RH, Kuzu B, Yetkin D, Alagöz MA, Dogen A, Burmaoglu S, Algul O (2022) 2-Phenyl substituted benzimidazole derivatives: design, synthesis, and evaluation of their antiproliferative and antimicrobial activities. Med Chem Res 31:1192–1208. https://doi.org/10.1007/s00044-022-02900-3 Kong Y, Wang K, Edler MC, Hamel E, Mooberry SL, Paige MA, Brown ML (2010) A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent. Bioorg Med Chem 18(2):971–977 Liu X, Go ML (2007) Antiproliferative activity of chalcones with basic functionalities. Bioorgan Med Chem 15(22):7021–7034. https://doi.org/10.1016/j.bmc.2007.07.042 Verpoorte JA, Mehta S, Edsall JT (1967) Esterase activities of human carbonic anhydrases B and C. J Biol Chem 242(18):4221–4229. https://doi.org/10.1016/S0021-9258(18)95800-X Yamali C, Gül Hİ, Demir Y, Kazaz C, Gülçin İ (2020) Synthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl) thio) ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitors. Turk J Chem 44(4):1058–1067. https://doi.org/10.3906/kim-2004-36 Aktaş A, Yakalı G, Demir Y, Gülçin İ, Aygün M, Gök Y (2022) The palladium-based complexes bearing 1, 3-dibenzylbenzimidazolium with morpholine, triphenylphosphine, and pyridine derivate ligands: synthesis, characterization, structure and enzyme inhibitions. Heliyon 8(9):e10625. https://doi.org/10.1016/j.heliyon.2022 Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95. https://doi.org/10.1016/0006-2952(61)90145-9 Palabıyık E, Sulumer AN, Uguz H, Avcı B, Askın S, Askın H, Demir Y (2022) Assessment of hypolipidemic and anti-inflammatory properties of walnut (Juglans regia) seed coat extract and modulates some metabolic enzymes activity in triton WR-1339-induced hyperlipidemia in rat kidney, liver, and heart. J Mol Recognit. https://doi.org/10.1002/jmr.3004 Demirci Ö, Tezcan B, Demir Y, Taskin-Tok T, Gök Y, Aktaş A, Gülçin İ (2022) Acetylphenyl-substituted imidazolium salts: synthesis, characterization, in silico studies and inhibitory properties against some metabolic enzymes. Mol Divers. https://doi.org/10.1007/s11030-022-10578-3 Lineweaver H, Burk D, Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56(3):658–666 Özaslan MS, Demir Y, Aksoy M, Küfrevioğlu ÖI, Beydemir Ş (2018) Inhibition effects of pesticides on glutathione-S-transferase enzyme activity of Van Lake fish liver. J Biochem Mol Toxicol 32(9):e22196. https://doi.org/10.1002/jbt.22196 Sever B, Altıntop MD, Demir Y, Türkeş C, Özbaş K, Çiftçi GA, Özdemir AA (2021) New series of 2, 4-thiazolidinediones endowed with potent aldose reductase inhibitory activity. Open Chem 19(1):347–357. https://doi.org/10.1515/chem-2021-0032 Nadaroglu H, Gungor AA, Gundogdu Ö, Kishali NH, Sever B, Altintop MD (2019) Investigation of the inhibitory effects of isoindoline-1, 3-dion derivatives on hCA-I and hCA-II enzyme activities. J Mol Struct 1197:386–392. https://doi.org/10.1016/j.molstruc.2019.07.070 Özçelik AB, Özdemir Z, Sari S, Utku S, Uysal M (2019) A new series of pyridazinone derivatives as cholinesterases inhibitors: synthesis, in vitro activity and molecular modeling studies. Pharmacol Rep 71:1253–1263. https://doi.org/10.1016/j.pharep.2019.07.006 Nose S (1984) A unified formulation of the constant temperature molecular dynamics methods. J Chem Phys 81(1):511–519 Martyna GJ, Tobias DJ, Klein ML (1994) Constant pressure molecular dynamics algorithms. J Chem Phys 101(5):4177–4189. https://doi.org/10.1063/1.467468 Ersan RH, Alagoz MA, Ertan-Bolelli T, Duran N, Burmaoglu S, Algul O (2021) Head-to-head bisbenzazole derivatives as antiproliferative agents: design, synthesis, in vitro activity, and SAR analysis. Mol Divers 25:2247–2259. https://doi.org/10.1007/s11030-020-10115-0 Ersan RH, Alagoz MA, Dogen A, Duran N, Burmaoglu S, Algul O (2022) Bisbenzoxazole derivatives: design, synthesis, in vitro antimicrobial, antiproliferative activity, and molecular docking studies. Polycycl Aromat Compd 42(6):3103–3123. https://doi.org/10.1080/10406638.2020.1852589 Anil D, Caykoylu EU, Sanli F, Gambacorta N, Karatas OF, Nicolotti O, Burmaoglu S (2021) Synthesis and biological evaluation of 3, 5-diaryl-pyrazole derivatives as potential antiprostate cancer agents. Arch Pharm 354(12):2100225. https://doi.org/10.1002/ardp.202100225 Kocyigit UM, Budak Y, Eligüzel F, Taslimi P, Kılıç D, Gulçin İ, Ceylan M (2017) Synthesis and carbonic anhydrase inhibition of tetrabromo chalcone derivatives. Arch Pharm. https://doi.org/10.1002/ardp.201700198 Stellenboom N (2019) Comparison of the inhibitory potential towards carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase of chalcone and chalcone epoxide. J Biochem Mol Toxicol 33(2):e22240. https://doi.org/10.1002/jbt.22240 Singh P, Swain B, Thacker PS, Sigalapalli DK, Purnachander Yadav P, Angeli A, Supuran CT, Arifuddin M (2020) Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1, 2, 3-triazole chalcone hybrids. Bioorg Chem 99:103839. https://doi.org/10.1016/j.bioorg.2020.103839 Burmaoglu S, Yilmaz AO, Polat MF, Kaya R, Gulcin İ, Algul O (2019) Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors. Bioorg Chem 85:191–197. https://doi.org/10.1016/j.bioorg.2018.12.035 Aslan HE, Demir Y, Özaslan MS, Türkan F, Beydemir Ş, Küfrevioğlu ÖI (2019) The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity. Drug Chem Toxicol 42(6):634–640. https://doi.org/10.1080/01480545.2018.1463242